Xue Snow G.
About Xue Snow G.
Xue Snow G. is the Senior Vice President of Clinical Pharmacology at BridgeBio, where she has worked since 2024. She holds a Ph.D. in Chemistry from The University of British Columbia and has extensive experience in clinical pharmacology and regulatory affairs.
Current Role at BridgeBio
Xue Snow G. serves as the Senior Vice President of Clinical Pharmacology at BridgeBio, a position held since 2024. In this role, G. is responsible for overseeing clinical pharmacology strategies and ensuring compliance with regulatory standards. Prior to this, G. held the position of Vice President of Clinical Pharmacology at BridgeBio from 2021 to 2023. This extensive experience within the organization highlights G.'s expertise in clinical pharmacology and regulatory affairs.
Education and Professional Development
Xue Snow G. has a strong educational background in chemistry, having earned a Ph.D. from The University of British Columbia and a BS from Peking University. G. also completed an Executive MBA at Quantic School of Business and Technology. In 2023, G. participated in the Executive Leadership Program at McKinsey & Company, further enhancing leadership skills and strategic thinking.
Previous Experience in Clinical Pharmacology
Before joining BridgeBio, Xue Snow G. accumulated significant experience in the field of clinical pharmacology. G. worked at Nektar Therapeutics as Senior Director of Clinical Pharmacology and Quantitative Sciences from 2011 to 2021. G. also held positions at Stiefel, a GSK company, as Associate Director, and at Schering AG / Berlex Biosciences as a Scientist in Drug Metabolism and Pharmacokinetics. This diverse background contributes to G.'s comprehensive understanding of the industry.
Involvement with Life Science Angels
Xue Snow G. has been a member of Life Science Angels since 2020, serving on the Biotherapeutics/Genomics Screening Committee. This role involves evaluating investment opportunities in the life sciences sector, demonstrating G.'s commitment to advancing biotherapeutics and genomics initiatives.
Expertise in Regulatory Affairs
Xue Snow G. possesses extensive knowledge of FDA and EMA regulations and guidelines. G. has achieved Regulatory Affairs Certification (RAC), which underscores a commitment to understanding and navigating regulatory frameworks essential for global drug approvals. This expertise is complemented by a proven track record in managing resources and budgets effectively.